Sign up now!
Don't show this again

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Poultry Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app


Collect articles and features into your own report to read later, print or share with others

Create a New Report


Read Later

Create a new report

Report title (required) Brief description (optional)
follow us

You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Poultry Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Sponsored By Zoetis

Featured Video Play Icon

Mycoplasma synoviae demanding more attention as poultry industry grasps its full impact

Emerging, variant strains of Mycoplasma synoviae (MS) are causing eggshell apex abnormalities as well as production drops in both layer and breeding flocks worldwide, Anneke Feberwee, DVM, PhD, from GD Animal Health, the Netherlands, told Poultry Health Today.

With the exception of primary breeding stock, MS is not yet under control and its economic relevance is finally becoming clear, presenting a new challenge for the industry, she said during the International Avian Respiratory Disease Conference.

The better known and better controlled Mycoplasma gallisepticum (MG) causes respiratory disease in broilers, layers and turkeys, and often leads to airsacculitis, mortality and condemnations, Feberwee said.

Both MS and MG can act synergistically with other respiratory tract pathogens, she noted.

Control measures for both species are based on the prevention or reduction of vertical and horizontal transmission. This means strict biosecurity and vaccination, and preventing direct contact between commercial chickens and wild birds, Feberwee said. She noted that although survival of MS and MG outside the host is relatively short, both pathogens can survive for months in egg debris.

Vaccination to reduce clinical signs of the disease has become common practice in many parts of the world. Recent research demonstrates that vaccination helps reduce shedding and horizontal transmission of both MS and MG, Feberwee said.

She emphasized that polymerase chain reaction (PCR) testing must be used to monitor field infections in vaccinated flocks. Differentiating Infected from Vaccinated Animals — DIVA — testing will become more important to monitor progression in mycoplasma control, she predicted.

Posted on February 27, 2019


You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.